Norwest Pharmaceuticals Private Limited
About Norwest Pharmaceuticals Private Limited
Data last updated:
Norwest Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 April 1984 and has been in existence for over 42 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1984PTC018048. Its GSTIN is 06AAACN1015D1ZA (Haryana).
The company has an authorised share capital of ₹12 Lakh and a paid-up capital of ₹12 Lakh. It is led by directors Sandhya Sawhney and Nitin Sawhney.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 99 Mansarovar Garden, New Delhi, Delhi, India – 110015.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.95 Lakh, a growth of 25% compared to the previous year. For the same year it recorded a net loss of ₹1.56 Lakh (net margin -15.7%) and EBITDA of -₹1.43 Lakh (EBITDA margin -14.4%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Norwest Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressE – 99 Mansarovar Garden, New Delhi, Delhi, India – 110015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Norwest Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Norwest Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Norwest Pharmaceuticals Private Limited, buy the company report.
Financials of Norwest Pharmaceuticals Private Limited
FY 2025 filings availableNorwest Pharmaceuticals Private Limited reported revenue of ₹9.95 Lakh (up 25% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 25% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 10%. EBITDA rose 59% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.43 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -14.4% | ||||
| Net Profit Margin | -15.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Norwest Pharmaceuticals Private Limited, buy the company report.
Board of directors of Norwest Pharmaceuticals Private Limited
Norwest Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandhya Sawhney | Director | 16 Aug 2010 | 16 Years 2 Months | Current |
| Nitin Sawhney | Director | 30 Sep 2022 | 4 Years 1 Months | Current |
Auditor
Norwest Pharmaceuticals Private Limited is audited by Vineet Garg & Co for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vineet Garg & Co | FY 2022 | 009744N |
Shareholding
The shareholding of Norwest Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Norwest Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Norwest Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Norwest Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Norwest Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAACN1015D1ZA | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Norwest Pharmaceuticals Private Limited, buy the company report.
Recent activity
Norwest Pharmaceuticals Private Limited has 4 board changes on record since 2010: 2 appointments and 2 cessations. The latest: Babal Suri ceased to be Director on 10 Oct 2022.
Frequently asked questions
Norwest Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 April 1984 (42+ years old) and is registered under CIN U74899DL1984PTC018048.
Norwest Pharmaceuticals has 2 current directors:
- Sandhya Sawhney - Director
- Nitin Sawhney - Director
The latest financial statements of Norwest Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Norwest Pharmaceuticals is 06AAACN1015D1ZA, registered in Haryana.
The CIN (Corporate Identification Number) of Norwest Pharmaceuticals is U74899DL1984PTC018048. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Norwest Pharmaceuticals was incorporated on 28 April 1984, making it 42+ years old. It is registered with the Registrar of Companies, Delhi.
Babal Suri ceased to be Director on 10 Oct 2022. Nitin Sawhney was appointed as Director on 30 Sep 2022. Sandhya Sawhney was appointed as Director on 16 Aug 2010. Norwest Pharmaceuticals has 4 board changes on record in total.
The registered office of Norwest Pharmaceuticals is at E – 99 Mansarovar Garden, New Delhi, Delhi, India – 110015.
Norwest Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Norwest Pharmaceuticals is compliant as of 19 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
